Anna Maria Nosari

Author PubWeight™ 9.69^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.	J Clin Oncol	2002	1.76
2	Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.	Blood	2002	1.35
3	Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature.	Leuk Res	2008	1.01
4	Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules.	Haematologica	2003	0.85
5	Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid.	Clin Lymphoma Myeloma	2008	0.82
6	Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.	Leuk Res	2009	0.81
7	Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients.	Clin Drug Investig	2011	0.81
8	Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.	J Chemother	2014	0.79
9	Total serum tryptase: a predictive marker for KIT mutation in acute myeloid leukemia.	Leuk Res	2009	0.76
10	A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne.	Hematol Oncol	2012	0.75
11	Radiofrequency ablation of hepatic Hodgkin lymphoma.	Leuk Lymphoma	2009	0.75
12	DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.	Transfusion	2008	0.75